04/02/2025
12:41 PM | Actuate Therapeutics (Issuer)
LYTLE PAUL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
12:43 PM | Actuate Therapeutics (Issuer)
Mazar Andrew Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
12:44 PM | Actuate Therapeutics (Issuer)
SCHMITT DANIEL M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2025
5:23 AM | Actuate Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
03/28/2025
5:00 AM | Actuate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2025
3:30 PM | Actuate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
3:00 PM | Actuate Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/24/2024
3:05 PM | Actuate Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/20/2024
7:45 PM | Actuate Therapeutics (Issuer)
Bios Equity Partners II, LP (Reporting)
Bios Equity Partners, LP (Reporting)
BIOS Fund I QP, LP (Reporting)
BIOS Fund I, LP (Reporting)
BIOS Fund II NT, LP (Reporting)
BIOS Fund II QP, LP (Reporting)
BIOS Fund II, LP (Reporting)
Cavu Advisors, LLC (Reporting)
Cavu Management, LP (Reporting)
Kreis Leslie W. (Reporting)
| Form 4/A | |
08/20/2024
7:46 PM | Actuate Therapeutics (Issuer)
BIOS Actuate Co-Invest I, LP (Reporting)
BIOS Actuate Co-Invest II, LP (Reporting)
Bios Actuate Co-Invest III, LP (Reporting)
BIOS Advisors GP, LLC (Reporting)
BIOS Capital Management, LP (Reporting)
BIOS Equity Partners III, LP (Reporting)
BIOS Fund III NT, LP (Reporting)
BIOS Fund III QP, LP (Reporting)
BIOS Fund III, LP (Reporting)
Fletcher Aaron G.L. (Reporting)
| Form 4/A | |
08/20/2024
7:46 PM | Actuate Therapeutics (Issuer)
Bios Clinical Opportunity Fund, LP (Reporting)
Bios Equity COF, LP (Reporting)
BP Directors, LP (Reporting)
| Form 4/A | |
Get the Latest News and Ratings for ACTU and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Actuate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
08/19/2024
7:59 PM | Actuate Therapeutics (Subject)
BIOS Fund I, LP (Filed by)
| Form SC 13D | |
08/19/2024
4:25 PM | Actuate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2024
8:12 PM | Actuate Therapeutics (Issuer)
Kairos SPV Fund LLC (Reporting)
Kairos Venture Opportunities I, L.P. (Reporting)
Kairos Venture Partners II, L.P. (Reporting)
Kairos-Actuate SPV, L.P. (Reporting)
THOMSON TODD S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
7:46 PM | Actuate Therapeutics (Issuer)
Bios Equity Partners II, LP (Reporting)
Bios Equity Partners, LP (Reporting)
BIOS Fund I QP, LP (Reporting)
BIOS Fund I, LP (Reporting)
BIOS Fund II NT, LP (Reporting)
BIOS Fund II QP, LP (Reporting)
BIOS Fund II, LP (Reporting)
Cavu Advisors, LLC (Reporting)
Cavu Management, LP (Reporting)
Kreis Leslie W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
7:49 PM | Actuate Therapeutics (Issuer)
BIOS Actuate Co-Invest I, LP (Reporting)
BIOS Actuate Co-Invest II, LP (Reporting)
Bios Actuate Co-Invest III, LP (Reporting)
BIOS Advisors GP, LLC (Reporting)
BIOS Capital Management, LP (Reporting)
BIOS Equity Partners III, LP (Reporting)
BIOS Fund III NT, LP (Reporting)
BIOS Fund III QP, LP (Reporting)
BIOS Fund III, LP (Reporting)
Fletcher Aaron G.L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
7:51 PM | Actuate Therapeutics (Issuer)
BIOS Actuate Co-Invest I, LP (Reporting)
BIOS Actuate Co-Invest II, LP (Reporting)
Bios Actuate Co-Invest III, LP (Reporting)
BIOS Advisors GP, LLC (Reporting)
BIOS Capital Management, LP (Reporting)
BIOS Equity Partners III, LP (Reporting)
BIOS Fund III NT, LP (Reporting)
BIOS Fund III QP, LP (Reporting)
BIOS Fund III, LP (Reporting)
Fletcher Aaron G.L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
7:54 PM | Actuate Therapeutics (Issuer)
Bios Clinical Opportunity Fund, LP (Reporting)
Bios Equity COF, LP (Reporting)
BP Directors, LP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
7:56 PM | Actuate Therapeutics (Issuer)
Bios Clinical Opportunity Fund, LP (Reporting)
Bios Equity COF, LP (Reporting)
BP Directors, LP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
7:44 PM | Actuate Therapeutics (Issuer)
Bios Equity Partners II, LP (Reporting)
Bios Equity Partners, LP (Reporting)
BIOS Fund I QP, LP (Reporting)
BIOS Fund I, LP (Reporting)
BIOS Fund II NT, LP (Reporting)
BIOS Fund II QP, LP (Reporting)
BIOS Fund II, LP (Reporting)
Cavu Advisors, LLC (Reporting)
Cavu Management, LP (Reporting)
Kreis Leslie W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
6:48 PM | Actuate Therapeutics (Issuer)
Bios 2024 Co-Invest, LP (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/14/2024
6:23 PM | Actuate Therapeutics (Issuer)
Sawhney Roger (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/14/2024
6:23 PM | Actuate Therapeutics (Issuer)
RONNEBERG AMY L (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/14/2024
6:25 PM | Actuate Therapeutics (Issuer)
Sawhney Roger (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
6:26 PM | Actuate Therapeutics (Issuer)
RONNEBERG AMY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
6:27 PM | Actuate Therapeutics (Issuer)
Keyes Jason A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
6:28 PM | Actuate Therapeutics (Issuer)
LYTLE PAUL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
6:29 PM | Actuate Therapeutics (Issuer)
SCHMITT DANIEL M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
6:30 PM | Actuate Therapeutics (Issuer)
Zabrowski Dan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
4:14 PM | Actuate Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/14/2024
3:37 PM | Actuate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
2:11 PM | Actuate Therapeutics (Filer)
| Form POS EX | |
08/13/2024
1:50 PM | Actuate Therapeutics (Filer)
| Form 424B4 | |
08/12/2024
11:15 PM | Actuate Therapeutics (Filer)
| Form EFFECT | |
08/12/2024
8:45 PM | Actuate Therapeutics (Issuer)
Keyes Jason A (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/12/2024
8:46 PM | Actuate Therapeutics (Issuer)
LYTLE PAUL J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/12/2024
8:47 PM | Actuate Therapeutics (Issuer)
Mazar Andrew Paul (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/12/2024
8:48 PM | Actuate Therapeutics (Issuer)
SCHMITT DANIEL M (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/12/2024
8:49 PM | Actuate Therapeutics (Issuer)
Zabrowski Dan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/12/2024
5:57 PM | Actuate Therapeutics (Issuer)
Kairos SPV Fund LLC (Reporting)
Kairos Venture Opportunities I, L.P. (Reporting)
Kairos Venture Partners II, L.P. (Reporting)
Kairos-Actuate SPV, L.P. (Reporting)
THOMSON TODD S (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/12/2024
5:29 PM | Actuate Therapeutics (Issuer)
Bios Equity Partners II, LP (Reporting)
Bios Equity Partners, LP (Reporting)
BIOS Fund I QP, LP (Reporting)
BIOS Fund I, LP (Reporting)
BIOS Fund II NT, LP (Reporting)
BIOS Fund II QP, LP (Reporting)
BIOS Fund II, LP (Reporting)
Cavu Advisors, LLC (Reporting)
Cavu Management, LP (Reporting)
Kreis Leslie W. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
Trump to unlock 15-figure fortune for America (May 3rd) ? (Ad) We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men in America.
Rickards has spent his fifty-year career in the innermost circles of the U.S. government and banking.
And he believes Trump could soon release this frozen asset to the public.
 But something even more spectacular is bound to happen. And those who know what to expect could make |
08/12/2024
5:30 PM | Actuate Therapeutics (Issuer)
BIOS Actuate Co-Invest I, LP (Reporting)
BIOS Actuate Co-Invest II, LP (Reporting)
Bios Actuate Co-Invest III, LP (Reporting)
BIOS Advisors GP, LLC (Reporting)
BIOS Capital Management, LP (Reporting)
BIOS Equity Partners III, LP (Reporting)
BIOS Fund III NT, LP (Reporting)
BIOS Fund III QP, LP (Reporting)
BIOS Fund III, LP (Reporting)
Fletcher Aaron G.L. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/12/2024
5:30 PM | Actuate Therapeutics (Issuer)
Bios Clinical Opportunity Fund, LP (Reporting)
Bios Equity COF, LP (Reporting)
BP Directors, LP (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/12/2024
12:35 PM | Actuate Therapeutics (Filer)
| Form CERT | |
08/12/2024
10:58 AM | Actuate Therapeutics (Filer)
| Form 8-A12B/A | |
07/23/2024
5:01 AM | Actuate Therapeutics (Filer)
| Form S-1/A | |
07/23/2024
5:01 AM | Actuate Therapeutics (Subject)
| Form FWP | |
07/19/2024
7:01 AM | Actuate Therapeutics (Subject)
| Form FWP | |
07/19/2024
6:58 AM | Actuate Therapeutics (Filer)
| Form S-1/A | |
07/16/2024
1:41 PM | Actuate Therapeutics (Filer)
| Form S-1/A | |
06/21/2024
4:12 PM | Actuate Therapeutics (Subject)
| Form FWP | |
06/21/2024
11:47 AM | Actuate Therapeutics (Filer)
| Form S-1/A | |
06/20/2024
8:40 AM | Actuate Therapeutics (Filer)
| Form 8-A12B | |
06/11/2024
6:01 AM | Actuate Therapeutics (Filer)
| Form S-1/A | |
06/11/2024
6:15 AM | Actuate Therapeutics (Subject)
| Form FWP | |
